AVONEX Multiple Sclerosis Treatment

Learn how starting AVONEX early may help
your multiple sclerosis patients continue to stay
active longer.¹

AVONEX is the only MS treatment for both Clinically Isolated Syndrome^a (CIS) and delay of physical disability, providing both early and long-term results.¹

See how CHAMPIONS 10 marks 10 years of clinical data in MS patients who first presented with Clinically Isolated Syndrome.¹ Learn More

Review these interactive MS case studies to learn how AVONEX may make a difference for MS patients in your practice. Learn More

AVONEX Prescribing Information View or download full prescribing information for AVONEX (interferon beta-1a) IM Injection. Learn More

AVONEX Medication Guide View or download instructions to learn how to use AVONEX Prefilled Syringes or the AVONEX vials. Learn More

Footnotes

^a People who have experienced a first attack and have lesions consistent with MS on their MRI.
^b Controlled High-Risk AVONEX Multiple Sclerosis Prevention Study in Ongoing Neurologic Surveillance.

References

Biogen Idec, internal data on file.

Biogen Idec™

Please see full Prescribing Information and Patient Medication Guide for AVONEX. ©2008 Biogen Idec. This site is intended for health care professionals who are residents of the United States, Puerto Rico, and US territories. AVONEX and MS ActiveSource® are registered trademarks of Biogen Idec.